T1	Participants 292 447	This study was carried out on 55 patients, who were either treated for six (n = 16) or 18 months (n = 39) and followed up for an additional two-year period
T2	Participants 449 582	TSAb was determined on whole serum in 29 patients before and at the end of treatment, and in 26 patients at the end of treatment only
T3	Participants 1395 1590	TSAb determined again during follow-up was negative in each of the 18 patients in remission, and positive in 8/10 patients at the time of relapse, whatever its level at the end of the drug course
